Aubagio (teriflunomide) is a prescription medication used to treat relapsing forms of multiple sclerosis (MS), including relapsing-remitting MS (RRMS), clinically isolated syndrome (CIS), and active secondary progressive MS (SPMS). It slows the progression of disability and reduces the frequency of relapses.